Publicacions en què col·labora amb Marta Ruiz Ortega (30)

2022

  1. CCN2 (Cellular Communication Network Factor 2) Deletion Alters Vascular Integrity and Function Predisposing to Aneurysm Formation

    Hypertension, Vol. 79, Núm. 3, pp. E42-E55

2018

  1. Branched-chain amino acids promote endothelial dysfunction through increased reactive oxygen species generation and inflammation

    Journal of Cellular and Molecular Medicine, Vol. 22, Núm. 10, pp. 4948-4962

2009

  1. Angiotensin-(1-7) and the G protein-coupled receptor Mas are key players in renal inflammation

    PLoS ONE, Vol. 4, Núm. 4

2008

  1. Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation

    Kidney International, Vol. 74, Núm. 5, pp. 585-595

  2. Inhibitory effect of interleukin-1β on angiotensin II-induced connective tissue growth factor and type IV collagen production in cultured mesangial cells

    American Journal of Physiology - Renal Physiology, Vol. 294, Núm. 1

  3. Parathyroid hormone-related protein promotes inflammation in the kidney with an obstructed ureter

    Kidney International, Vol. 73, Núm. 7, pp. 835-847

2007

  1. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: Role of RhoA/ROCK and MAPK pathways

    Hypertension, Vol. 50, Núm. 2, pp. 377-383

  2. The Regulation of the Inflammatory Response Through Nuclear Factor-κB Pathway by Angiotensin IV Extends the Role of the Renin Angiotensin System in Cardiovascular Diseases

    Trends in Cardiovascular Medicine, Vol. 17, Núm. 1, pp. 19-25

2006

  1. Angiotensin II: A key factor in the inflammatory and fibrotic response in kidney diseases

    Nephrology Dialysis Transplantation, Vol. 21, Núm. 1, pp. 16-20

  2. Long-term treatment with an ACE inhibitor or an AT1 antagonist avoids hypertension-induced inflammation in the kidney

    Journal of Nephrology, Vol. 19, Núm. 6, pp. 725-731

  3. Renal and vascular hypertension-induced inflammation: Role of angiotensin II

    Current Opinion in Nephrology and Hypertension, Vol. 15, Núm. 2, pp. 159-166

  4. Role of parathyroid hormone-related protein in tubulointerstitial apoptosis and fibrosis after folic acid-induced nephrotoxicity

    Journal of the American Society of Nephrology, Vol. 17, Núm. 6, pp. 1594-1603

2005

  1. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-β-independent mechanism

    Circulation, Vol. 111, Núm. 19, pp. 2509-2517

  2. Angiotensin II regulates vascular endothelial growth factor via hypoxia-inducible factor-1α induction and redox mechanisms in the kidney

    Antioxidants and Redox Signaling, Vol. 7, Núm. 9-10, pp. 1275-1284

  3. Angiotensin IV activates the nuclear transcription factor-κB and related proinflammatory genes in vascular smooth muscle cells

    Circulation Research, Vol. 96, Núm. 9, pp. 965-973

  4. Endothelin-1, via ETA receptor and independently of transforming growth factor-β, increases the connective tissue growth factor in vascular smooth muscle cells

    Circulation Research, Vol. 97, Núm. 2, pp. 125-134

  5. The Rho-kinase pathway regulates angiotensin II-induced renal damage

    Kidney International

2004

  1. Angiotensin II, via AT1 and AT2 receptors and NF-κB pathway, regulates the inflammatory response in unilateral ureteral obstruction

    Journal of the American Society of Nephrology, Vol. 15, Núm. 6, pp. 1514-1529

  2. Angiotensina II: Auténtica citoquina en el daño vascular

    Nefrologia, Vol. 24, Núm. SUPPL.1, pp. 26

  3. Los inhibidores de la HMG-CoA reductasa regulan la síntesis del factor de crecimiento de tejido conectivo (CTGF) inducido por la angiotensina II. ¿Un efecto adicional vasoprotector?

    Investigacion Cardiovascular, Vol. 7, Núm. 1, pp. 60-80